The Unnatural History of the Left Ventricle After Double Switch Operation for Congenitally Corrected Transposition of the Great Arteries with Intact Ventricular Septum: Dilation is the Norm
Pediatric Cardiology · 06.08.2026
DOI: 10.1007/s00246-026-04404-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, online erschienen am 06.08.2026. Verfasst von Deepak Gupta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Boston Children's Hospital, Boston, MA, USA. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Double Switch Operation (DSO) for congenitally-corrected transposition of the great arteries/intact ventricular septum (ccTGA/IVS) restores the morphologic left ventricle (LV) to the systemic position. While outcomes have been studied using the LV ejection fraction (EF) as a metric, little is known about LV volumetric remodeling over time. This retrospective single-center study describes the volumetric evolution of the LV from 302 echocardiograms in 70 patients with ccTGA/IVS who underwent DSO. Echocardiographic measurements of LV end-diastolic volume (EDV) and end-systolic volume (ESV) Z-scores, mass, and EF were recorded. Cubic spline modeling was used to evaluate temporal trends in volumetric parameters. LV EDV and ESV Z-scores rose acutely post-DSO and continued to rise until ~ 4 years post-DSO. LVEF declined slightly acutely post-DSO (pre-DSO 54% [46, 62], discharge study 48% [38, 54], p < 0.001) and then stabilized. LV mass increased, but mass-to-volume ratio declined over time, consistent with eccentric hypertrophy. Univariate analysis showed that any neo-aortic regurgitation at discharge was associated with increased dilation (EDV Z-score change + 1.08, p = 0.002). Lower pre-DSO LV: RV pressure ratio was associated with the greatest acute dilation (top 10th percentile Z-score change from pre-DSO to discharge, OR 1.65 per 0.1-unit decrease, p = 0.033), though this association did not hold when using a top 20th percentile Z-score change cut-point. The LV in ccTGA/IVS patients undergoes acute and sustained dilation and eccentric hypertrophy after DSO. Neo-aortic regurgitation and lower pre-DSO LV: RV pressure ratio may be associated with dilation. Multi-center outcome studies are warranted to determine the clinical implications of this remodeling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Boston Children's Hospital, Boston, MA, USA.
- Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
- Children's Hospital of Richmond, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Cardiology, Boston Children's Hospital, Boston, MA, USA. Nikhil.Thatte@cardio.chboston.org.
- Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Nikhil.Thatte@cardio.chboston.org.
Zitieren
APA
Gupta, D., Sterling-Lovy, S., Lipsitz, S., Fu, Y., Aly, S., Beroukhim, R. S., Ghelani, S. J., Schidlow, D. N., & Thatte, N. (2026). The Unnatural History of the Left Ventricle After Double Switch Operation for Congenitally Corrected Transposition of the Great Arteries with Intact Ventricular Septum: Dilation is the Norm. Pediatric Cardiology. https://doi.org/10.1007/s00246-026-04404-y
Vancouver
Gupta D, Sterling-Lovy S, Lipsitz S, Fu Y, Aly S, Beroukhim RS, et al. The Unnatural History of the Left Ventricle After Double Switch Operation for Congenitally Corrected Transposition of the Great Arteries with Intact Ventricular Septum: Dilation is the Norm. Pediatric Cardiology. 2026. doi:10.1007/s00246-026-04404-y
BibTeX
@article{Gupta2026,
author = {Gupta, Deepak and Sterling-Lovy, Shanique and Lipsitz, Stuart and Fu, Yuanyuan and Aly, Safwat and Beroukhim, Rebecca S and Ghelani, Sunil J and Schidlow, David N and Thatte, Nikhil},
title = {The Unnatural History of the Left Ventricle After Double Switch Operation for Congenitally Corrected Transposition of the Great Arteries with Intact Ventricular Septum: Dilation is the Norm},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-026-04404-y}
}
EUVIMED